The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436).
J. R. Infante
No relevant relationships to disclose
G. S. Falchook
Research Funding - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
D. P. Lawrence
No relevant relationships to disclose
J. S. Weber
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
R. F. Kefford
Consultant or Advisory Role - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
J. C. Bendell
No relevant relationships to disclose
R. Kurzrock
Research Funding - GlaxoSmithKline
G. Shapiro
Research Funding - GlaxoSmithKline
R. R. Kudchadkar
No relevant relationships to disclose
G. V. Long
Consultant or Advisory Role - GlaxoSmithKline (U)
H. A. Burris
No relevant relationships to disclose
K. B. Kim
Research Funding - GlaxoSmithKline
A. Clements
No relevant relationships to disclose
S. Peng
Employment or Leadership Position - GlaxoSmithKline
B. Yi
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
A. J. Allred
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
D. Ouellet
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
K. Patel
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
P. F. Lebowitz
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
K. T. Flaherty
Consultant or Advisory Role - GlaxoSmithKline